Delve Bio is a genomic diagnostics company commercializing clinical metagenomic next-generation sequencing (mNGS) for infectious disease diagnosis. Its flagship test, Delve Detect, analyzes all nucleic acids in a single cerebrospinal fluid sample to simultaneously detect bacteria, viruses, fungi, and parasites, screening against a curated database… - View it on GitHub